Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Investor Newsletters
18-Mar-2021
Kazia March 2021 Newsletter
17-Mar-2020
Kazia March 2020 newsletter
26-Sep-2019
Kazia September 2019 newsletter
24-Jun-2019
Kazia June 2019 Newsletter
14-Feb-2019
Kazia February 2019 newsletter
5-Nov-2018
Kazia November 2018 Newsletter
11-May-2018
Kazia May 2018 Newsletter
7-Jun-2017
Novogen June 2017 newsletter
21-Feb-2017
Novogen February 2017 Newsletter
